We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEdinburgh Investment Trust PLC Regulatory News (EDIN)

Share Price Information for Edinburgh Investment Trust PLC (EDIN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 722.00
Bid: 721.00
Ask: 724.00
Change: 0.00 (0.00%)
Spread: 3.00 (0.416%)
Open: 724.00
High: 726.00
Low: 721.00
Prev. Close: 722.00
EDIN Live PriceLast checked at -
Edinburgh Investment is an Investment Trust

To achieve an increase of the NAV per share in excess of the growth in the FTSE All-Share Index and dividend growth that exceeds UK inflation rate by investing primarily in UK securities.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results analysis from Kepler Trust Intelligence

31 May 2023 11:43

RNS Number : 1883B
Edinburgh Investment Trust PLC
31 May 2023
 

Edinburgh Investment Trust (EDIN)

31/05/2023

Results analysis from Kepler Trust Intelligence

Edinburgh Investment Trust (EDIN) has delivered strong outperformance of the benchmark in the year to 31/03/2023, with a NAV total return of 7.9% comparing to a 2.9% total return for the FTSE All Share Index. EDIN's share price return was 8.4%.

EDIN has outperformed the FTSE handsomely since James de Uphaugh was appointed manager in March 2020, with a NAV total return of 65.9% and share price total return of 75.5%, both well above the 47.4% total return of the benchmark.

During the year the board refinanced EDIN's long-term debt at much more attractive terms, the new borrowings being taken out at 2.44% p.a. compared to the rate of 7.75% on the previous debt.

Kepler View

These are good results which contribute to a strong track record since the change of management in March 2020. Pleasingly, the drivers of return have been diverse at the stock level in the period under review, with BAE Systems, Natwest and Centrica amongst the biggest contributors, along with Greggs, Standard Chartered and Weir. James has positioned the portfolio to have exposure to multiple themes. While holdings in banks and energy-related names, sectors benefitting from high inflation or high rates, have helped returns in the recent past, the portfolio is also exposed to an improving picture for the UK consumer, with James arguing a peak in inflation and interest rates is likely to relieve the pressure on households over the coming year. Meanwhile, the UK remains cheap versus international peers, after being out of favour for a number of years. This could provide further impetus behind Edinburgh Investment Trust's (EDIN) returns, with the potential for an improving economic backdrop to see that valuation differential close.

One major supportive factor for the trust going forward is the improved gearing position. The trust had suffered in the past thanks to having very expensive long-term debt. The board arranged cheaper debt to replace it in late 2021, locking in a highly advantageous rate before the cost of debt rose once more over 2022. This means James has plenty of cheap cash to put to work in the market, which should be supportive of returns over the course of a cycle as markets rise. NAV returns of the trust have benefitted over 2022 as rising interest rates cut the fair value of this newly rearranged debt, adding 4 percentage points to NAV total returns.

CLICK HERE TO READ THE FULL REPORT  Visit Kepler Trust Intelligence for more high quality independent investment trust research.

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFZGFKGMRGFZM
Date   Source Headline
29th Apr 202411:29 amRNSNet Asset Value(s)
26th Apr 202411:31 amRNSNet Asset Value(s)
25th Apr 202411:09 amRNSNet Asset Value(s)
24th Apr 202411:40 amRNSNet Asset Value(s)
24th Apr 20247:00 amRNSDividend Declaration
23rd Apr 202411:03 amRNSNet Asset Value(s)
22nd Apr 20245:16 pmRNSTransaction in Own Shares
22nd Apr 202410:55 amRNSNet Asset Value(s)
19th Apr 202411:06 amRNSNet Asset Value(s)
18th Apr 202411:06 amRNSNet Asset Value(s)
18th Apr 20248:45 amRNSCompliance with Market Abuse Regulation
17th Apr 202410:56 amRNSNet Asset Value(s)
16th Apr 202410:42 amRNSNet Asset Value(s)
15th Apr 20245:09 pmRNSTransaction in Own Shares
15th Apr 20245:05 pmRNSDirector/PDMR Shareholding
15th Apr 202411:04 amRNSNet Asset Value(s)
15th Apr 20249:22 amRNSDirector Declaration
12th Apr 202410:54 amRNSNet Asset Value(s)
11th Apr 20245:12 pmRNSTransaction in Own Shares
11th Apr 202411:18 amRNSNet Asset Value(s)
10th Apr 20245:39 pmRNSTransaction in Own Shares
10th Apr 202410:41 amRNSNet Asset Value(s)
9th Apr 20245:24 pmRNSTransaction in Own Shares
9th Apr 202411:17 amRNSNet Asset Value(s)
8th Apr 20245:29 pmRNSTransaction in Own Shares
8th Apr 202410:18 amRNSNet Asset Value(s)
5th Apr 202410:58 amRNSNet Asset Value(s)
4th Apr 202411:24 amRNSNet Asset Value(s)
3rd Apr 20245:40 pmRNSTransaction in Own Shares
3rd Apr 202411:38 amRNSNet Asset Value(s)
2nd Apr 20245:29 pmRNSTransaction in Own Shares
2nd Apr 202411:31 amRNSNet Asset Value(s)
2nd Apr 202411:09 amRNSTotal Voting Rights
28th Mar 20245:28 pmRNSTransaction in Own Shares
28th Mar 202411:41 amRNSNet Asset Value(s)
27th Mar 20245:15 pmRNSTransaction in Own Shares
27th Mar 202411:09 amRNSNet Asset Value(s)
26th Mar 20245:31 pmRNSTransaction in Own Shares
26th Mar 20242:12 pmRNSDirector/PDMR Shareholding
26th Mar 202410:27 amRNSNet Asset Value(s)
25th Mar 20245:03 pmRNSTransaction in Own Shares
25th Mar 202410:45 amRNSNet Asset Value(s)
22nd Mar 20245:21 pmRNSTransaction in Own Shares
22nd Mar 202411:09 amRNSNet Asset Value(s)
21st Mar 20245:26 pmRNSTransaction in Own Shares
21st Mar 202410:47 amRNSNet Asset Value(s)
20th Mar 20245:53 pmRNSTransaction in Own Shares
20th Mar 202410:37 amRNSNet Asset Value(s)
19th Mar 20245:19 pmRNSTransaction in Own Shares
19th Mar 202410:39 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.